Dry Needling Versus Intramuscular Stimulation in the Management of the Myofascial Trigger Points

Not Applicable

Completed

• Conditions: Trigger Point Pain, Myofascial; Muscle Pain; Myofascial Pain Syndrome
• Interventions: Other: Dry needling and electric stimulation; Other: Dry needling

• Registration Number: NCT03025230
• Lead Sponsor: University of Alcala

Brief Summary

Hypothesis The application of intramuscular electrostimulation will be more effectiveness than the dry needling in myofascial trigger points treatment.

Objetives:

To determine the effectiveness of intramuscular electrostimulation in the treatment of trigger points of the levator scapula muscle for the improvement of pain in mechanical cervicalgia.

Participants: Subjects with diagnosed of myofascial pain syndrome in cervical region and active trigger points in levator scapulae muscle, randomly assigned to experimental or control group.

Intervention: Control group: one session of dry needling in active trigger points; experimental group: one session of intramuscular stimulation in active trigger points.

Main Outcomes Measures: Pain, pressure pain threshold (PPT), active cervical range of motion and strength muscle . The measures will be taken before, after and one week after the interventions.

Detailed Description

The muscle pain is one of the most common forms of musculoskeletal pain. Within muscular pain, the presence of myofascial trigger points (PG) in the musculature is a important and prevalent problem.

Currently one the techniques most used in the treatment of PG is dry needling. Dry needling has been shown effective in the treatment of neck pain associated with PGs.

To our knowledge, there are no studies that they have compared the effectiveness of dry needling and intramuscular stimulation by applying an electric current.

This study is a randomized clinical trial that aims to demonstrate that the application of an electric current associated with dry needling in the treatment of PG.

In this study we will treat subjects with cervical pain who they have active PGs in the levator scapulae muscle.

Study Timeline

• Study Start: 2016-12
• Study First Submitted: 2017-01-16
• Study First Submitted QC: 2017-01-16
• Study First Posted: 2017-01-19
• Primary Completion: 2017-03
• Study Completion: 2017-07
• Status Verified: 2024-05
• Last Update Submitted: 2024-05-07
• Last Update Posted: 2024-05-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Cervical pain.
• Active trigger points in levator scapulae muscle

Exclusion Criteria

• Pain Irradiation toward upper limb
• Psychological disorders
• Whiplash.
• Neuropathic symptoms
• Cervical and / or Shoulder Spine Surgery

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Experimental group	Dry needling and electric stimulation	Dry needling technique and the application of a rectangular, biphasic, asymmetric analgesic electric current by selecting a frequency of 2 Hz with a pulse width 40 μs, with an intensity located at the tolerance threshold and for a time of 20 minutes.
Control group	Dry needling	Dry technique in PG.The needle will be moved in-and-out into different directions to encounter sensitive spots in PG region.

Primary Outcome Measures

Name	Time	Method
Pressure Pain Threshold (PPT)	Change from baseline at one week	An algometer Wagner FPI 10-WA will be used to determine the PPT in levator scapulae trigger points

Secondary Outcome Measures

Name	Time	Method
Strength in cervical latero-flexion	Change from baseline at one week	Dynamic dynamometry with MicroFet-2 will be used while patients will positioned in seated. From this position, patients will performed lateral - flexion
Pain Visual Analogue Scale	Change from baseline at one week	The pain VAS is a unidimensional measure of pain intensity, which has been widely used in diverse adult populations. The VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured from 0 (no pain) to 10 (maximum pain). All the subjects will showed their pain level.

Trial Locations

Locations (1)

Patricia Martínez Merinero; 🇪🇸 Alcala de Henares, Madrid, Spain